Home›Stock Screener›ANG Lifesciences

ANG Lifesciences Share Price Today | Stock Price & ANG Lifesciences Share Screener

ANG Pharmaceuticals
Live Share Price BSE
₹39.38
▼ -0.80 (-1.99%)
2026-10-05 00:00:00

As of October 5, 2026, the live ANG Lifesciences share price (BSE: ANG) is ₹39.38, down 1.99% from the previous close, with shares trading between ₹39.38 and ₹39.50 in today's trading session, and a 52-week range of ₹18.42–₹42.83. Check ANG price range for the annual price range and momentum. Use the ANG Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today ANG Lifesciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹24 and net income of ₹-1, with EBITDA of ₹3, an operating margin of 11.0% and a profit margin of -4.2%.

ANG Lifesciences Market Cap ₹52.53 Cr.
ANG P/E Ratio (TTM) -4.03
ANG Lifesciences P/B Ratio 1.01
EPS (TTM) ₹-8.43
Dividend Yield -
Debt to Equity 1.11
ANG 52 Week High ₹42.83
ANG Lifesciences 52 Week Low ₹18.42
Operating Margin 11.00%
Profit Margin -4.17%
ANG Revenue (TTM) ₹24.00
EBITDA ₹3.00
Net Income ₹-1.00
Total Assets ₹209.00
Total Equity ₹53.00

ANG Lifesciences Share Price Chart

Track the current stock price of ANG Lifesciences with an interactive chart. Analyse ANG share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete ANG Lifesciences stock quote in one place.

The quote of ₹39.38 sits between the 52-week low of ₹18.42 and the 52-week high of ₹42.83, and the latest session moved -1.99% from the previous close.

ANG Lifesciences Company Profile - Fundamental Screener

Screen ANG Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ANG shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE236W01016.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE236W01016

ANG Lifesciences Balance Sheet Screener

Screen ANG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹209, down from ₹230 in 2025.

Latest statistics put total assets at ₹209 and shareholder funds at ₹53, with a leverage ratio of 1.11.

Item 2026 2025 2024 2023 2022

Assets

Total Assets 209 230 242 278 291
Current Assets 145 161 173 183 193
Fixed Assets 51 57 58 88 93

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 7 22 22 29 41
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 53 64 76 86 84
Share Capital 13 13 13 13 10
Reserves & Surplus 40 46 59 69 69

ANG Lifesciences Income Statement Screener - Profit & Revenue Analysis

Screen ANG Lifesciences income statement and profit fundamentals. Analyze ANG quarterly results. ANG Lifesciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹24 and net profit was ₹-1, equal to earnings per unit of ₹-1.07, at an operating margin of 11%.

In that period expenses were ₹21, interest cost ₹2 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹15 and net profit of ₹-4.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar

Revenue and Expenses

Revenue 24 15 18 25 26 19 38 20 33 25 49 57 34 19 96
Expenses 21 17 18 24 26 21 36 20 31 27 50 50 32 21 83

Operating Costs and Margins

EBITDA 3 -2 0 1 0 -3 2 0 3 -2 -1 7 2 -2 13
Operating Profit % 11.00% -13.00% -4.00% 3.00% 0.00% -14.00% 4.00% -9.00% 7.00% -9.00% -26.00% 12.00% 5.00% -10.00% 13.00%
Depreciation 2 2 1 2 2 2 2 2 2 2 3 2 2 2 3
Interest 2 2 2 2 2 2 4 2 2 2 2 2 2 3 4

Profit and Earnings

Profit Before Tax -1 -6 -4 -3 -3 -6 -4 -4 -1 -6 -6 2 -3 -6 7
Tax 0 -1 -2 -1 0 -1 0 -1 1 -1 -1 1 0 0 2
Net Profit -1 -4 -2 -2 -3 -5 -4 -3 -2 -5 -5 2 -2 -6 5
EPS -1.07 -3.24 -1.56 -1.52 -2.24 -3.60 -2.75 -2.35 -1.53 -3.98 -3.63 1.41 -1.74 -4.52 5.16

ANG Lifesciences Cash Flow Screener - Liquidity Fundamentals

Screen ANG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹0.

Over the same period, investing activities used ₹2 and financing activities provided ₹2.

Item 2025-March 2024-March 2023-March 2022-March

Cash from Operations and Investing

Operating Activities 0 -10 26 25
Investing Activities -2 20 -9 -44

Financing and Net Cash

Financing Activities 2 -10 -17 20
Net Cash Flow 0 0 0 0

ANG Lifesciences Shareholding Pattern Screener

See ANG Lifesciences shareholding pattern with promoter, FII, and DII holdings. Check ANG Lifesciences promoter holding and ownership changes for ANG on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 70.60%, foreign institutions 0.00%, domestic institutions 0.00% and the public 26.30%, spread across 5,946 shareholders.

The shareholder count was 5,946 in 2026-Jun, compared with 5,952 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept

Promoter Holding

Promoter Holding 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 26.30% 26.21% 26.26% 26.18% 26.11% 26.11% 25.92% 25.45%
Other Holding 3.10% 3.19% 3.13% 3.21% 3.29% 3.29% 3.48% 3.95%
Shareholder Count 5,946 5,952 6,084 6,273 6,400 6,508 6,517 6,468

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by ANG Lifesciences. ANG Lifesciences dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹1.00 1.33%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

ANG Lifesciences Stock Index Membership - Nifty & Sensex

See which indices include ANG Lifesciences stock. Check ANG index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

ANG Lifesciences is not part of any tracked indices.
Only major market indices are tracked in our system.

ANG Lifesciences Market Events Screener - Corporate Actions

Get ANG Lifesciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check ANG Lifesciences stock events that may affect ANG share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.

It is followed by Quarterly Result Announcement dated August 14, 2026 and Quarterly Result Announcement dated May 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-30 2026-09-30 Annual General Meeting NA 20.48%
2026-08-14 2026-08-14 Quarterly Result Announcement NA -2.33%
2026-05-30 2026-05-30 Quarterly Result Announcement NA -5.73%
2026-02-14 2026-02-14 Quarterly Result Announcement NA 3.50%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -2.04%
2025-09-30 2025-09-30 Annual General Meeting NA -1.68%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -3.93%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -5.27%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -5.83%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -4.04%
2024-09-30 2024-09-30 Annual General Meeting NA -8.62%
2022-07-13 2022-07-14 Bonus 1:4 36.04%
2021-11-02 2021-11-04 Dividend ₹ 1.00 /share 47.69%
2021-09-22 Bonus 1:1 -

ANG Lifesciences Competitors Screener - Peer Stocks Comparison

Screen ANG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 447,476 36.44 61,674 12.69% 11,565 40.74
Divis Laboratories 250,363 86.51 11,067 13.95% 2,568 63.87
Torrent Pharmaceuticals 186,152 85.91 13,886 20.34% 2,138 46.50
Zydus Life Science 120,798 26.32 27,658 17.64% 5,026 66.57
Cipla 111,426 33.44 29,045 2.24% 3,870 45.42
Laurus Labs 106,838 99.70 6,868 22.01% 890 64.04
Mankind Pharma 105,107 48.73 14,636 14.85% 1,938 55.24
Dr Reddys Laboratories 104,492 32.05 35,059 3.90% 4,158 63.11
Aurobindo Pharma 97,682 26.36 34,145 5.56% 3,503 54.66
Lupin 93,829 16.99 29,039 26.75% 5,356 35.30

ANG Lifesciences Company Announcements - News & Reports Screener

Screen ANG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 30, 2026.

The next most recent announcements are dated September 7, 2026 and September 7, 2026.

Date Update Actions
2026-09-30 Closure of Trading Window -
2026-09-07 Reg. 34 (1) Annual Report. -
2026-09-07 Notice Of 20Th AGM Of The Company On Wednesday 30Th September 2026 At 12 :00 Noon. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OA VM). -
2026-09-07 Intimation Of Book Closure -
2026-09-07 Intimation Of 20Th Annual General Meeting -
2026-09-07 Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Intimation Of AGM -
2026-08-14 Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations 2015 -
2026-08-14 Board Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations 2015 -
2026-08-07 Board Meeting Intimation for Consideration And Approval Of Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30-06-2026. -
2026-07-21 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-19 Closure of Trading Window -
2026-06-05 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-30 Results - 31.03.2026 -
2026-05-30 Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended 31St March 2026 -
2026-05-29 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-22 Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026 -
2026-04-17 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-15 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-10 Clarification On Price Movement In Shares -
2026-04-10 Clarification sought from ANG Lifesciences India Ltd -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹39.38, within a 52-week range of ₹18.42 to ₹42.83. The P/E ratio is -4.03 and the P/B ratio is 1.01, with earnings per unit of ₹-8.43. Market capitalisation stands at ₹52.53 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 5 balance sheet periods, 15 income statement periods, 4 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.